immunity News and Research

RSS

High fat diet linked to increased risk of relapse in kids with MS

On the other hand, high vegetable intake may halve the risk of relapse, the findings indicate. Several genetic and environmental factors, including previous infection with Epstein Barr virus, exposure to cigarette smoke, and low vitamin D levels have all been associated with a heightened risk of MS.

9 Oct 2017

Penn study explains how acute viral infections can linger

Infections caused by viruses, such as respiratory syncytial virus, or RSV, measles, parainfluenza, and Ebola, are typically considered acute. These viruses cause disease quickly and live within a host for a limited time. But in some cases, the effects of the infection, and presence of the virus itself, can persist.

6 Oct 2017

Ebola vaccine found to be safe and effective for adults and children in Africa

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

6 Oct 2017

Nutrition-related strategies may modify inflammation of aging, report reveals

Aging is characterized by increased levels of inflammatory markers in the bloodstream, a phenomenon that has been termed "inflammaging". This type of enhanced inflammation tone, also designated as low grade inflammation, is associated with age-related decline of many functional systems and with increased risk of sickness, poor well-being and mortality.

6 Oct 2017

Vitamin D supplement can help boost immunity during winter months

Vitamin D is the only supplement worth taking to boost immunity for the coming winter and to help prevent colds, according to experts on ITV’s Save Money: Good Health.

From BetterYou Ltd 6 Oct 2017

Columbia University receives $9.6 million NIH grant for ME/CFS research center

The National Institutes of Health has awarded a five-year $9.6 million grant to the Center for Infection and Immunity at Columbia University's Mailman School of Public Health to create the Center for Solutions for Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (CfS for ME/CFS), an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

27 Sep 2017

Positive mood on the day of flu jab can increase its protective effect, research finds

New research by a team of health experts at the University of Nottingham has found evidence that being in a positive mood on the day of your flu jab can increase its protective effect.

26 Sep 2017

Hard water may contribute to development of eczema by damaging skin barrier

Researchers from the University of Sheffield and King’s College London have discovered that exposing the skin to hard water damages the skin barrier – which is our defense against outside threats such as bacteria or sun burn – and increases the sensitivity of the skin to potential irritants found in everyday wash products such as soap or washing powder.

22 Sep 2017

Triple-action antibody to be tested as HIV vaccine

Scientists from the National Institutes of Health (NIH) in collaboration with the pharmaceutical company Sanofi have engineered a three-pronged antibody that protected monkeys from two strains of Human Immunodeficiency Virus (HIV) better than the equivalent naturally occurring antibodies.

22 Sep 2017

Global resurgence of whooping cough can be attributed to immunological failures of vaccines

The startling global resurgence of pertussis, or whooping cough, in recent years can largely be attributed to the immunological failures of acellular vaccines, Boston University School of Public Health researchers argue in a new journal article.

21 Sep 2017

New study shows how staph cells evade the body's immune system

For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.

21 Sep 2017

Researchers identify role of tumor-infiltrating B-cells in melanoma progression, resistance to therapy

In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified the role of tumor-infiltrating or tumor-associated B-cells ("TABs") in melanoma progression and resistance to targeted therapy.

20 Sep 2017

Salk study shows how fast-growing tumors evade immune system

The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor immunity.

18 Sep 2017

Carbohydrates on surface of malaria parasites could be key to effective vaccine

An international research team has shown for the first time that carbohydrates on the surface of malaria parasites play a critical role in malaria's ability to infect mosquito and human hosts.

18 Sep 2017

Research shows link between brain's immune system and desire to drink alcohol

Researchers from the University of Adelaide have found a new link between the brain's immune system and the desire to drink alcohol in the evening.

15 Sep 2017

New discovery by TSRI scientists could speed efforts to develop effective HIV vaccine

Scientists at The Scripps Research Institute have made a discovery that could speed efforts to develop a successful HIV vaccine.

14 Sep 2017

New shingles vaccine gets FDA panel votes

On the 13th of September 2017, a U.S. Food and Drug Administration (FDA) advisory panel has voted 11 to 0 approving a shingles vaccine for its use in adults aged 50 and over. The panel unanimously accepted the safety and efficacy of the vaccine and thus GlaxoSmithKline’s Shingrix is on its way to FDA approval.

14 Sep 2017

Researchers develop new model to tackle patients with cryptosporidiosis-HIV co-infection

One of the most common waterborne diseases worldwide is cryptosporidiosis, a parasitic disease affecting the small intestine and possibly our airways. It is a common cause of diarrhoea in HIV-positive patients, who are known to have lower immunity.

13 Sep 2017

BioCote Silver Ion Antimicrobial Technology makes surfaces inhospitable to influenza viruses

Strike a chord please, especially in light of the BMJ's article on Tuesday about the ineffectiveness of the flu vaccine for elderly last year - just wanted to make you also aware of the ultimate surface protection against viruses like H1N1, plus all the proliferating superbugs.

11 Sep 2017

Meningitis B vaccine’s high price tag poses a health care conundrum

Four years ago, when meningitis B, an extremely rare but potentially lethal form of the infection, sickened a small number of college students at Princeton and the University of California-Santa Barbara, there was no vaccine against the disease sold in the U.S. Despite its availability abroad, it had never been licensed in the country due to its limited marketability.

8 Sep 2017